Strategies in postoperative analgesia in the obese obstructive sleep apnea patient

Clinical Journal of Pain

Volumn 29, Issue 11, 2013, Pages 998-1005

  Porhomayon, Jahan ^a   Leissner, Kay B ^d,e   El Solh, Ali A ^b   Nader, Nader D ^c  

^a Division of Critical Care Medicine   (United States)

^b Division of Pulmonary Critical Care and Sleep Medicine   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

monitoring; obstructive sleep apnea; pain; respiratory; screening; surgery

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; ANTIINFLAMMATORY AGENT; ANTIPYRETIC AGENT; DEXAMETHASONE; DEXMEDETOMIDINE; FENTANYL; KETAMINE; KETOROLAC; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OPIATE RECEPTOR; PARACETAMOL; PARECOXIB; SEDATIVE AGENT; THIOPENTAL; TRAMADOL;

ADVERSE OUTCOME; AIRWAY OBSTRUCTION; ANALGESIA; ARTICLE; BODY MASS; BODY WEIGHT; DRUG CLEARANCE; DRUG SAFETY; HUMAN; HYPOXEMIA; INTRAOPERATIVE PERIOD; OBESITY; PATHOPHYSIOLOGY; PATIENT CONTROLLED ANALGESIA; PHARYNGEAL MUSCLE; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; REM SLEEP; RESPIRATORY FAILURE; SEDATION; SLEEP DISORDERED BREATHING; SLEEP TIME; SURGICAL RISK; UNITED STATES;

ANALGESICS; HUMANS; OBESITY; PAIN, POSTOPERATIVE; SLEEP APNEA, OBSTRUCTIVE;

EID: 84885425777     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e31827c7bc7     Document Type: Article

References (116)

1. Isono S. Obesity and obstructive sleep apnoea: mechanisms for increased collapsibility of the passive pharyngeal airway. Respirology. 2012;17:32-42.
2. Aronow WS. Cardiovascular manifestations seen in obstructive sleep apnea. Compr Ther. 2007;33:82-86.
3. Resnick HE, Redline S, Shahar E, et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care. 2003;26:702-709.
4. Pedrosa RP, Drager LF, Gonzaga CC, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58: 811-817.
5. Parra O, Sanchez-Armengol A, Bonnin M, et al. Early treatment of obstructive apnoea and stroke outcome: a randomised controlled trial. Eur Respir J. 2011;37:1128-1136.
6. Shepherd KL, Chambers DC, Gabbay E, et al. Obstructive sleep apnoea and nocturnal gastroesophageal reflux are common in lung transplant patients. Respirology. 2008;13:1045-1052.
7. Agrawal S, Sharma SK, Sreenivas V, et al. Prevalence of metabolic syndrome in a north Indian hospital-based population with obstructive sleep apnoea. Indian J Med Res. 2011;134:639-644.
8. Sand T, Hagen K, Schrader H. Sleep apnoea and chronic headache. Cephalalgia. 2003;23:90-95.
9. Prisco DL, Sica AL, Talwar A, et al. Correlation of pulmonary hypertension severity with metrics of comorbid sleep-disordered breathing. Sleep Breath. 2011;15:633-639.
10. Samper-Ternent R, Al Snih S. Obesity in older adults: epidemiology and implications for disability and disease. Rev Clin Gerontol. 2012;22:10-34.
11. Gibson GJ. Obstructive sleep apnoea syndrome: underestimated and undertreated. Br Med Bull. 2004;72:49-65.
12. Benumof JL. Obesity, sleep apnea, the airway and anesthesia. Curr Opin Anaesthesiol. 2004;17:21-30.
13. Suleiman LI, Ortega G, Ong'uti SK, et al. Does BMI affect perioperative complications following total knee and hip arthroplasty? J Surg Res. 2012;174:7-11.
14. Ebert TJ, Shankar H, Haake RM. Perioperative considerations for patients with morbid obesity. Anesthesiol Clin. 2006;24:621-636.
15. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76-79.
16. Ogden CL, Yanovski SZ, Carroll MD, et al. The epidemiology of obesity. Gastroenterology. 2007;132:2087-2102.
17. Sturm R. Increases in morbid obesity in the USA: 2000-2005. Public Health. 2007;121:492-496.
18. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230-1235.
19. Davies RJ, Stradling JR. The epidemiology of sleep apnoea. Thorax. 1996;51(suppl 2):S65-S70.
20. Chung SA, Yuan H, Chung F. A systemic review of obstructive sleep apnea and its implications for anesthesiologists. Anesth Analg. 2008;107:1543-1563.
21. Kaw R, Golish J, Ghamande S, et al. Incremental risk of obstructive sleep apnea on cardiac surgical outcomes. J Cardiovasc Surg (Torino). 2006;47:683-689.
22. Akinnusi ME, Saliba R, Porhomayon J, et al. Sleep disorders in morbid obesity. Eur J Intern Med. 2012;23:219-226.
23. Kuna ST, Remmers JE. Neural and anatomic factors related to upper airway occlusion during sleep. Med Clin North Am. 1985;69:1221-1242.
24. Gaultier C. Upper airway muscles and physiopathology of obstructive sleep apnea syndrome. Neurophysiol Clin. 1994; 24:195-206.
25. Horner RL, Guz A. Some factors affecting the maintenance of upper airway patency in man. Respir Med. 1991;85(suppl A): 27-30.
26. Mayer P, Pepin JL, Bettega G, et al. Relationship between body mass index, age and upper airway measurements in snorers and sleep apnoea patients. Eur Respir J. 1996;9:1801-1809.
27. Guilleminault C. Sleep apnea syndrome. Presse Med. 1984;13:433-436.
28. Macintyre PE, Loadsman JA, Scott DA. Opioids, ventilation and acute pain management. Anaesth Intensive Care. 2011;39: 545-558.
29. Chung F. It may be unsafe for patients with untreated severe OSA requiring postoperative narcotic to undergo ambulatory surgery. J Clin Sleep Med. 2011;7:111, Author reply 112-113.
30. Wang D, Teichtahl H. Opioids, sleep architecture and sleep-disordered breathing. Sleep Med Rev. 2007;11:35-46.
31. Teichtahl H, Wang D. Sleep-disordered breathing with chronic opioid use. Expert Opin Drug Saf. 2007;6:641-649.
32. Farney RJ, Walker JM, Cloward TV, et al. Sleep-disordered breathing associated with long-term opioid therapy. Chest. 2003;123:632-639.
33. Walker JM, Farney RJ, Rhondeau SM, et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med. 2007;3:455-461.
34. Geller AS. Opioid overdose-related deaths. JAMA. 2011;306: 379, Author reply 380-371.
35. Wang D, Teichtahl H, Drummer O, et al. Central sleep apnea in stable methadone maintenance treatment patients. Chest. 2005;128:1348-1356.
36. Gay PC. Sleep and sleep-disordered breathing in the hospitalized patient. Respir Care. 2010;55:1240-1254.
37. Arisaka H, Sakuraba S, Kobayashi R, et al. Perioperative management of obstructive sleep apnea with nasal continuous positive airway pressure. Anesth Prog. 2008;55:121-123.
38. Taylor S, Kirton OC, Staff I, et al. Postoperative day one: a high risk period for respiratory events. Am J Surg. 2005; 190:752-756.
39. Weingarten TN, Sprung J, Flores A, et al. Opioid requirements after laparoscopic bariatric surgery. Obes Surg. 2011;21:1407-1412.
40. Blouin RA, Kolpek JH, Mann HJ. Influence of obesity on drug disposition. Clin Pharm. 1987;6:706-714.
41. Duffull SB, Dooley MJ, Green B, et al. A standard weight descriptor for dose adjustment in the obese patient. Clin Pharmacokinet. 2004;43:1167-1178.
42. Janmahasatian S, Duffull SB, Ash S, et al. Quantification of lean bodyweight. Clin Pharmacokinet. 2005;44:1051-1065.
43. Linares OA, Linares AL. Computational opioid prescribing: a novel application of clinical pharmacokinetics. J Pain Palliat Care Pharmacother. 2011;25:125-135.
44. Daszkiewicz A, Wylezol M. Postoperative analgesia in a morbidly obese patient with chronic renal failure. Anestezjol Intens Ter. 2010;42:197-200.
45. Tierney NM, Pollard BJ, Doran BR. Obstructive sleep apnoea. Anaesthesia. 1989;44:235-237.
46. Ogonowska-Kobusiewicz M, Rutyna R, Nestorowicz A. Perioperative risk in patients with sleep apnoea. Anestezjol Intens Ter. 2008;40:182-187.
47. 2. Zentralbl Chir. 2009;134:43-49.
48. Connolly LA. Anesthetic management of obstructive sleep apnea patients. J Clin Anesth. 1991;3:461-469.
49. Schnoor J, Ilgner J, Hein M, et al. Perioperative management of patients with obstructive sleep apnoea. Anaesthesist. 2009;58:189-198. quiz 199-200.
50. Ejnell H, Bjorkman R, Wahlander L, et al. Treatment of postoperative pain with diclofenac in uvulopalatopharyngo-plasty. Br J Anaesth. 1992;68:76-80.
51. Olkkola KT, Hamunen K, Seppala T, et al. Pharmacokinetics and ventilatory effects of intravenous oxycodone in postoperative children. Br J Clin Pharmacol. 1994;38:71-76.
52. Lirzin JD, Jorrot JC, Romdhane K, et al. Postoperative respiratory depression following ambulatory anesthesia for abortion. Evolution of the ventilatory response to CO2 following the use of propofol alone or in association with different opioids: comparison with midazolam in the same situation. Cah Anesthesiol. 1993;41:23-27.
53. Catley DM, Thornton C, Jordan C, et al. Pronounced, episodic oxygen desaturation in the postoperative period: its association with ventilatory pattern and analgesic regimen. Anesthesiology. 1985;63:20-28.
54. Ramachandran SK, Haider N, Saran KA, et al. Life-threatening critical respiratory events: a retrospective study of postoperative patients found unresponsive during analgesic therapy. J Clin Anesth. 2011;23:207-213.
55. Blake DW, Yew CY, Donnan GB, et al. Postoperative analgesia and respiratory events in patients with symptoms of obstructive sleep apnoea. Anaesth Intensive Care. 2009;37: 720-725.
56. Hullett BJ, Chambers NA, Pascoe EM, et al. Tramadol vs. morphine during adenotonsillectomy for obstructive sleep apnea in children. Paediatr Anaesth. 2006;16:648-653.
57. Bernards CM, Knowlton SL, Schmidt DF, et al. Respiratory and sleep effects of remifentanil in volunteers with moderate obstructive sleep apnea. Anesthesiology. 2009;110:41-49.
58. Guilleminault C, Cao M, Yue HJ, et al. Obstructive sleep apnea and chronic opioid use. Lung. 2010;188:459-468.
59. Mogri M, Khan MI, Grant BJ, et al. Central sleep apnea induced by acute ingestion of opioids. Chest. 2008;133:1484-1488.
60. Esclamado RM, Glenn MG, McCulloch TM, et al. Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome. Laryngoscope. 1989;99: 1125-1129.
61. Chawla S, Robinson S, Norton A, et al. Peri-operative use of dexmedetomidine in airway reconstruction surgery for obstructive sleep apnoea. J Laryngol Otol. 2010;124:67-72.
62. Javaheri S, Malik A, Smith J, et al. Adaptive pressure support servoventilation: a novel treatment for sleep apnea associated with use of opioids. J Clin Sleep Med. 2008;4:305-310.
63. Aspinall RL, Mayor A. A prospective randomized controlled study of the efficacy of ketamine for postoperative pain relief in children after adenotonsillectomy. Paediatr Anaesth. 2001;11:333-336.
64. Clyburn PA, Rosen M, Vickers MD. Comparison of the respiratory effects of i.v. infusions of morphine and regional analgesia by extradural block. Br J Anaesth. 1990;64:446-449.
65. Patel A, Davidson M, Tran MC, et al. Dexmedetomidine infusion for analgesia and prevention of emergence agitation in children with obstructive sleep apnea syndrome undergoing tonsillectomy and adenoidectomy. Anesth Analg. 2010;111: 1004-1010.
66. Dholakia C, Beverstein G, Garren M, et al. The impact of perioperative dexmedetomidine infusion on postoperative narcotic use and duration of stay after laparoscopic bariatric surgery. J Gastrointest Surg. 2007;11:1556-1559.
67. Plunkett AR, Shields C, Stojadinovic A, et al. Awake thyroidectomy under local anesthesia and dexmedetomidine infusion. Mil Med. 2009;174:100-102.
68. Luscri N, Tobias JD. Monitored anesthesia care with a combination of ketamine and dexmedetomidine during magnetic resonance imaging in three children with trisomy 21 and obstructive sleep apnea. Paediatr Anaesth. 2006;16:782-786.
69. Gorocs TS, Lambert M, Rinne T, et al. Efficacy and tolerability of ready-to-use intravenous paracetamol solution as monotherapy or as an adjunct analgesic therapy for postoperative pain in patients undergoing elective ambulatory surgery: open, prospective study. Int J Clin Pract. 2009;63: 112-120.
70. Savransky V, Reinke C, Jun J, et al. Chronic intermittent hypoxia and acetaminophen induce synergistic liver injury in mice. Exp Physiol. 2009;94:228-239.
71. Corcoran GB, Wong BK. Obesity as a risk factor in drug-induced organ injury: increased liver and kidney damage by acetaminophen in the obese overfed rat. J Pharmacol Exp Ther. 1987;241:921-927.
72. Raghavendran S, Bagry H, Detheux G, et al. An anesthetic management protocol to decrease respiratory complications after adenotonsillectomy in children with severe sleep apnea. Anesth Analg. 2010;110:1093-1101.
73. Mattila K, Kontinen VK, Kalso E, et al. Dexamethasone decreases oxycodone consumption following osteotomy of the first metatarsal bone: a randomized controlled trial in day surgery. Acta Anaesthesiol Scand. 2010;54:268-276.
74. Kapala M, Meterissian S, Schricker T. Neuraxial anesthesia and intraoperative bilevel positive airway pressure in a patient with severe chronic obstructive pulmonary disease and obstructive sleep apnea undergoing elective sigmoid resection. Reg Anesth Pain Med. 2009;34:69-71.
75. Pellecchia DJ, Bretz KA, Barnette RE. Postoperative pain control by means of epidural narcotics in a patient with obstructive sleep apnea. Anesth Analg. 1987;66:280-282.
76. Hendolin H, Kansanen M, Koski E, et al. Propofol-nitrous oxide versus thiopentone-isoflurane-nitrous oxide anaesthesia for uvulopalatopharyngoplasty in patients with sleep apnea. Acta Anaesthesiol Scand. 1994;38:694-698.
77. Schug SA, Torrie JJ. Safety assessment of postoperative pain management by an acute pain service. Pain. 1993;55:387-391.
78. Catley DM. Postoperative analgesia and respiratory control. Int Anesthesiol Clin. 1984;22:95-111.
79. Huang HC, Lee LA, Fang TJ, et al. Transnasal butorphanol for pain relief after uvulopalatopharyngoplasty-a hospital-based, randomized study. Chang Gung Med J. 2009;32: 390-399.
80. Grossmann W, Jurna I. Proceedings: the effect of morphine on neuronal membranes. Naunyn Schmiedebergs Arch Pharmacol. 1974;282(suppl):R228, 367-377.
81. Joris J. Efficacy of nonsteroidal antiinflammatory drugs in postoperative pain. Acta Anaesthesiol Belg. 1996;47:115-123.
82. Walker JS. NSAID: an update on their analgesic effects. Clin Exp Pharmacol Physiol. 1995;22:855-860.
83. Nuutinen LS, Laitinen JO, Salomaki TE. A risk-benefit appraisal of injectable NSAIDs in the management of postoperative pain. Drug Saf. 1993;9:380-393.
84. Hawkey CJ. COX-1 and COX-2 inhibitors. Best Pract Res Clin Gastroenterol. 2001;15:801-820.
85. Funk CD, FitzGerald GA. COX-2 inhibitors and cardiovascular risk. J Cardiovasc Pharmacol. 2007;50:470-479.
86. Adarsh E, Mane R, Sanikop C, et al. Effect of pre-operative rectal diclofenac suppository on post-operative analgesic requirement in cleft palate repair: a randomised clinical trial. Indian J Anaesth. 2012;56:265-269.
87. Shah P, Subnis B, Varshney A, et al. Clinical efficacy of a novel new injectable diclofenac formulation designed for intradeltoid use in post-operative pain management. Int J Clin Pharmacol Ther. 2011;49:286-290.
88. Nze PU, Onyekwulu F. Intraoperative diclofenac for post-adenoidectomy analgesia in small children. Niger J Clin Pract. 2006;9:102-104.
89. Seo YJ, Yoon H. The effects of preemptive analgesia of morphine and ketorolac on postoperative pain, cortisol, O(2) saturation and heart rate. J Korean Acad Nurs. 2008;38: 720-729.
90. Pieri M, Meacci L, Santini L, et al. Control of acute pain after major abdominal surgery in 585 patients given tramadol and ketorolac by intravenous infusion. Drugs Exp Clin Res. 2002;28:113-118.
91. Warner TD, Giuliano F, Vojnovic I, et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygen-ase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA. 1999;96: 7563-7568.
92. Smith HS, Voss B. Pharmacokinetics of intravenous ibupro-fen: implications of time of infusion in the treatment of pain and fever. Drugs. 2012;72:327-337.
93. Gallelli L, Colosimo M, Pirritano D, et al. Retrospective evaluation of adverse drug reactions induced by nonsteroidal anti-inflammatory drugs. Clin Drug Investig. 2007;27:115-122.
94. Yadeau JT, Paroli L, Kahn RL, et al. Addition of pregabalin to multimodal analgesic therapy following ankle surgery: a randomized double-blind, placebo-controlled trial. Reg Anesth Pain Med. 2012;37:302-307.
95. Skjelbred P, Lokken P. Reduction of pain and swelling by a corticosteroid injected 3 hours after surgery. Eur J Clin Pharmacol. 1982;23:141-146.
96. Stamer UM, Maier C, Grond S, et al. Tramadol in the management of post-operative pain: a double-blind, placeboand active drug-controlled study. Eur J Anaesthesiol. 1997;14:646-654.
97. Staahl C, Drewes AM, Jensen NH. Tapentadol is a new, strongly efficative analgeticum with dual effect mechanisms. Ugeskr Laeger. 2011;173:1796-1799.
98. Valtolina C, Robben JH, Uilenreef J, et al. Clinical evaluation of the efficacy and safety of a constant rate infusion of dexmedetomidine for postoperative pain management in dogs. Vet Anaesth Analg. 2009;36:369-383.
99. Buvanendran A, Kroin JS, Della Valle CJ, et al. Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: a prospective, randomized, controlled trial. Anesth Analg. 2010;110:199-207.
100. Eipe N, Penning J. Postoperative respiratory depression with pregabalin: a case series and a preoperative decision algorithm. Pain Res Manag. 2011;16:353-356.
101. Lehmann KA. Tramadol in acute pain. Drugs. 1997;53(suppl 2): 25-33.
102. Gentil B, Lienhart A, Fleury B. Enhancement of postoperative desaturation in heavy snorers. Anesth Analg. 1995;81:389-392.
103. Jones JG, Sapsford DJ, Wheatley RG. Postoperative hypoxaemia: mechanisms and time course. Anaesthesia. 1990;45:566-573.
104. Ingrande J, Lemmens HJ. Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth. 2010;105(suppl 1):i16-i23.
105. Mickelson SA. Anesthetic and postoperative management of the obstructive sleep apnea patient. Oral Maxillofac Surg Clin North Am. 2009;21:425-434.
106. Payen JF, Jaber S, Levy P, et al. Obstructive sleep-apnoea syndrome in adult and its perioperative management. Ann Fr Anesth Reanim. 2010;29:787-792.
107. Seet E, Chung F. Management of sleep apnea in adults-functional algorithms for the perioperative period: continuing professional development. Can J Anaesth. 2010;57:849-864.
108. Ramar K. Reversal of sleep-disordered breathing with opioid withdrawal. Pain Pract. 2009;9:394-398.
109. Heinzer R. Opioids and sleep disordered breathing. Rev Med Suisse. 2009;5:2322-2324, 2326-2328.
110. Bolden N, Smith CE, Auckley D, et al. Perioperative complications during use of an obstructive sleep apnea protocol following surgery and anesthesia. Anesth Analg. 2007;105:1869-1870.
111. Hirshkowitz M, Sharafkhaneh A. Positive airway pressure therapy of OSA. Semin Respir Crit Care Med. 2005;26:68-79.
112. Cullen KA, Hall MJ, Golosinskiy A. Ambulatory surgery in the United States, 2006. Natl Health Stat Report. 2009;1-25.
113. Stierer TL, Wright C, George A, et al. Risk assessment of obstructive sleep apnea in a population of patients undergoing ambulatory surgery. J Clin Sleep Med. 2010;6:467-472.
114. Gross JB, Bachenberg KL, Benumof JL, et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology. 2006;104:1081-1093; quiz 1117-1088.
115. Ankichetty S, Chung F. Considerations for patients with obstructive sleep apnea undergoing ambulatory surgery. Curr Opin Anaesthesiol. 2011;24:605-611.
116. Seet E, Chung F. Obstructive sleep apnea: preoperative assessment. Anesthesiol Clin. 2010;28:199-215.